CAM
EDIT icon

Close Asset Management’s Editas Medicine EDIT Stock Holding History

Close Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10
Closed – – 202
2022
Q3 		$0 Hold
10
– – ﹤0.01% 189
2022
Q2 		$0 Sell
10
-770
-99% -$10.3K ﹤0.01% 196
2022
Q1 		$21K Hold
780
– – ﹤0.01% 164
2021
Q4 		$21K Hold
780
– – ﹤0.01% 164
2021
Q3 		$32K Sell
780
-473
-38% -$25.9K ﹤0.01% 148
2021
Q2 		$71K Buy
1,253
+1,250
+41,667% +$46.2K ﹤0.01% 117
2021
Q1 		$0 Buy
+3
New +$171 ﹤0.01% 218

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Close Asset Management's EDIT Position: Q4 2022 in Review

Close Asset Management sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 10 shares.

Close Asset Management first reported a position in EDIT in Q1 2021 and held it in 7 quarters. The position peaked at $71K in Q2 2021. 250 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.

  • Close Asset Management reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
  • Close Asset Management sold 10 Editas Medicine shares in Q4 2022.
  • Close Asset Management first reported a position in Editas Medicine in Q1 2021 and held it in 7 quarters.
  • Close Asset Management's Editas Medicine position peaked at $71K in Q2 2021.
  • 250 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.

Based on Close Asset Management's 13F filing for Q4 2022, filed 27 Jan 2023.